367 related articles for article (PubMed ID: 9288042)
21. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM
Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601
[TBL] [Abstract][Full Text] [Related]
22. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
[TBL] [Abstract][Full Text] [Related]
23. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
24. Overview of Cochrane thrombolysis meta-analysis.
Wardlaw JM
Neurology; 2001; 57(5 Suppl 2):S69-76. PubMed ID: 11552059
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulants for acute ischaemic stroke.
Gubitz G; Sandercock P; Counsell C
Cochrane Database Syst Rev; 2004; (3):CD000024. PubMed ID: 15266421
[TBL] [Abstract][Full Text] [Related]
26. Thrombolysis in cerebral ischemia. A review of clinical and experimental data.
Puca A
J Neurosurg Sci; 1993 Jun; 37(2):63-70. PubMed ID: 8301372
[TBL] [Abstract][Full Text] [Related]
27. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
28. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
Lancet; 1994 Feb; 343(8893):311-22. PubMed ID: 7905143
[TBL] [Abstract][Full Text] [Related]
29. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
Eissa A; Krass I; Bajorek BV
J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
[TBL] [Abstract][Full Text] [Related]
30. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
31. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
32. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
[TBL] [Abstract][Full Text] [Related]
33. Thrombolytic therapy for ischemic stroke--a review. Part I--Intravenous thrombolysis.
Schellinger PD; Fiebach JB; Mohr A; Ringleb PA; Jansen O; Hacke W
Crit Care Med; 2001 Sep; 29(9):1812-8. PubMed ID: 11546993
[TBL] [Abstract][Full Text] [Related]
34. [Thrombolysis in acute cerebral ischemia].
von Kummer R; Forsting M; Wildemann B; Sartor K
Aktuelle Radiol; 1993 Nov; 3(6):351-5. PubMed ID: 8241298
[TBL] [Abstract][Full Text] [Related]
35. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
36. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
37. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
38. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.
Lancet; 1995 Dec; 346(8989):1509-14. PubMed ID: 7491044
[TBL] [Abstract][Full Text] [Related]
39. Thrombolytic therapy in cerebrovascular disorders.
Levine SR; Brott TG
Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
[TBL] [Abstract][Full Text] [Related]
40. Thrombolysis for acute stroke: a new era in treatment.
Gress DR; Bonovich D
Am Fam Physician; 1997 Jun; 55(8):2590-1. PubMed ID: 9191443
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
